Eculizumab as rescue therapy in severe resistant lupus nephritis

Detalles Bibliográficos
Autores principales: Pickering, Matthew C., Ismajli, Mediola, Condon, Marie B., McKenna, Nicola, Hall, Angela E., Lightstone, Liz, Terence Cook, H., Cairns, Thomas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643725/
https://www.ncbi.nlm.nih.gov/pubmed/26316577
http://dx.doi.org/10.1093/rheumatology/kev307
_version_ 1782400554607050752
author Pickering, Matthew C.
Ismajli, Mediola
Condon, Marie B.
McKenna, Nicola
Hall, Angela E.
Lightstone, Liz
Terence Cook, H.
Cairns, Thomas D.
author_facet Pickering, Matthew C.
Ismajli, Mediola
Condon, Marie B.
McKenna, Nicola
Hall, Angela E.
Lightstone, Liz
Terence Cook, H.
Cairns, Thomas D.
author_sort Pickering, Matthew C.
collection PubMed
description
format Online
Article
Text
id pubmed-4643725
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-46437252015-11-16 Eculizumab as rescue therapy in severe resistant lupus nephritis Pickering, Matthew C. Ismajli, Mediola Condon, Marie B. McKenna, Nicola Hall, Angela E. Lightstone, Liz Terence Cook, H. Cairns, Thomas D. Rheumatology (Oxford) Letters to the Editor Oxford University Press 2015-12 2015-08-27 /pmc/articles/PMC4643725/ /pubmed/26316577 http://dx.doi.org/10.1093/rheumatology/kev307 Text en © The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Pickering, Matthew C.
Ismajli, Mediola
Condon, Marie B.
McKenna, Nicola
Hall, Angela E.
Lightstone, Liz
Terence Cook, H.
Cairns, Thomas D.
Eculizumab as rescue therapy in severe resistant lupus nephritis
title Eculizumab as rescue therapy in severe resistant lupus nephritis
title_full Eculizumab as rescue therapy in severe resistant lupus nephritis
title_fullStr Eculizumab as rescue therapy in severe resistant lupus nephritis
title_full_unstemmed Eculizumab as rescue therapy in severe resistant lupus nephritis
title_short Eculizumab as rescue therapy in severe resistant lupus nephritis
title_sort eculizumab as rescue therapy in severe resistant lupus nephritis
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643725/
https://www.ncbi.nlm.nih.gov/pubmed/26316577
http://dx.doi.org/10.1093/rheumatology/kev307
work_keys_str_mv AT pickeringmatthewc eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT ismajlimediola eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT condonmarieb eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT mckennanicola eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT hallangelae eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT lightstoneliz eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT terencecookh eculizumabasrescuetherapyinsevereresistantlupusnephritis
AT cairnsthomasd eculizumabasrescuetherapyinsevereresistantlupusnephritis

Ejemplares similares